The enzymology of palmitate addition to lipid A can be traced to the early discovery of monosaccharide lipid A precursors, but the functional importance of lipid A palmitoylation in bacterial resistance to the host immune response has emerged only recently. Lipid A palmitoylation in enterobacteria is determined by a PhoP/PhoQ-activated gene pagP, which encodes an unusual outer membrane enzyme of lipid A biosynthesis. PagP structure and dynamics have now been elucidated by both NMR spectroscopy and Xray crystallography. PagP is an 8-stranded antiparallel b-barrel preceded by an N-terminal amphipathic a-helix. The PagP barrel axis is uniquely tilted by 30°with respect to the membrane normal. An interior hydrophobic pocket in the upper half of the molecule functions as a hydrocarbon ruler, which allows the enzyme to distinguish palmitate from other acyl chains found in phospholipids. Internalization of a phospholipid palmitoyl group within the barrel appears to occur by lateral diffusion from the outer leaflet through non-hydrogen bonded regions between b-strands. The MsbA-dependent trafficking of lipids from the inner membrane to the outer membrane outer leaflet is necessary for lipid A palmitoylation in vivo. Efforts to determine the PagP catalytic mechanism may lead to the development of inhibitors for the treatment of infections.
INTRODUCTION
The enzymology of palmitate addition to lipid A can be traced to the discovery of monosaccharide lipid A precursors. The recent completion of the Raetz pathway for lipid A biosynthesis 1 hinged on the serendipitous discovery of lipids X and Y in a conditional phosphatidylglycerol-deficient pgsA mutant of Escherichia coli in 1979. 2 Lipid X was subsequently shown to be a diacylglucosmine 1-phosphate bearing R-3-hydroxymyristoyl groups at positions 2 and 3, while lipid Y only differed from lipid X by the presence of a palmitoyl group in acyloxyacyl linkage at position 2. 3, 4 The accumulation of these glucosamine-based phospholipids in the phosphatidylglycerol-deficient mutant proved to be a consequence of a second unlinked conditional mutation in the gene pgsB (lpxB), 5, 6 which encodes the lipid A disaccharide synthase. LpxB generates the b-1¢,6-glycosidic bond that is a characteristic feature of lipid A. 7 Both lipids X and Y could activate macrophages in a similar manner as lipid A, 8 but only lipid X proved to be a substrate for LpxB, 7 raising doubts about the physiological significance of lipid Y.
While only trace amounts of palmitate were known to be present in lipid A from E. coli, roughly 20% of lipid A was found to contain palmitate in Salmonella spp. 9, 10 Initial efforts to characterize the enzymology of lipid A palmitoylation were partly motivated by the desire to reveal a general mechanism for the synthesis of acyloxyacyl linkages in lipid A. The discovery of a membrane-bound enzyme from E. coli that could generate lipid Y by transferring a palmitoyl group from the sn-1 position of a phospholipid to lipid X was reported in 1987 ( Fig. 1 ). 11 The enzyme was also shown to palmitoylate the disaccharide lipid A precursor lipid IV A . However, it was subsequently shown that the constitutive acyloxyacyl-linked lauroyl and myristoyl groups in lipid A were derived not from phospholipids, but from thiol esters of acyl carrier protein, 12 and studies of lipid A palmitoylation waned for a decade.
Interest in lipid A palmitoylation was revived in 1997 when it was shown that several regulated covalent modifications of lipid A, including palmitoylation, were controlled by the Salmonella PhoP/PhoQ two-component virulence signal transduction pathway, 13 which responds to Mg 2+ -limited growth conditions encountered during infection. 14 A PhoP/PhoQ-activated gene pagP was then identified in a Salmonella mutant that exhibited both a deficiency in lipid A palmitoylation and a hypersensitivity to vertebrate cationic antimicrobial peptides. 15 Palmitoylated lipid A was subsequently established to function as an endotoxin antagonist in human cell lines. 16 These observations indicated that PagP may function to help pathogenic bacteria evade the host immune response. PagP homologues are now known to be necessary for disease causation in the respiratory pathogens Legionella pneumophila and Bordetella bronchiseptica. 17, 18 In B. bronchiseptica, PagP is controlled by a different two-component virulence signal transduction pathway known as BvgA/BvgS. 18 PagP homologues are found in Escherichia, Yersinia, and Erwinia spp., in addition to Salmonella, Legionella, and Bordetella, all of which can adopt pathogenic lifestyles. Current efforts to understand the structure and function of PagP are aimed at developing a treatment for infections caused by this important group of pathogens.
RESULTS AND DISCUSSION
Each of the constitutive enzymes of the Raetz pathway utilize cytoplasmic substrates and are restricted to either the cytoplasm or the inner membrane. 1 Hydrophobicity analysis of the deduced PagP amino acid sequence led to the initial conclusion that PagP was likely not an enzyme, but a periplasmic protein that functioned to regulate lipid A palmitoylation. 15 However, many outer membrane proteins are difficult to distinguish from periplasmic proteins on the basis of hydrophobicity analysis alone. The enzyme that palmitoylates lipid X uses a phospholipid as the palmitoyl donor and could reasonably be localized in the outer membrane where both lipid A and phospholipids reside. 11 Indeed, PagP was established to be the first outer membrane enzyme of lipid A biosynthesis and remains the only such enzyme in E. coli. 19 Additional outer membrane enzymes of lipid A biosynthesis have since been discovered in Salmonella and Rhizobium leguminosarum. 20, 21 PagP palmitoylates lipid X in vitro, but the outer membrane localization of the enzyme indicates that the cytoplasmic lipid X cannot be the physiological substrate. 19 The simplest chemotype of lipopolysaccharide that is normally assembled in outer membranes of E. coli bears two 3-deoxy-D-manno-2-octulosonic acid (Kdo) sugars attached to position 6¢ of lipid A and is known as Kdo 2lipid A or Re endotoxin. 1 As expected, Kdo 2 -lipid A was shown to be an excellent acceptor for PagP catalyzed 108 Bishop, Lo, Khan, El Zoeiby, Jia palmitoylation from phospholipid donors in vitro. 19 The palmitoylation of lipid X observed in lpxB mutants is likely a consequence of lipid re-organization in membranes under the non-permissive conditions for lipid A biosynthesis combined with the relaxed specificity of PagP for lipid A acceptors.
PagP palmitoylates the N-linked R-3-hydroxymyristate chain at position 2 of lipid A in the enterobacteria, 15, 22 but Bordetella PagP palmitoylates the O-linked chain at position 3¢. 18 Pseudomonas aeruginosa also palmitoylates lipid A at position 3¢, 23 but no PagP homologue is apparent in the genome of this organism. 24 The nature of the acyl group transferred by the Legionella PagP homologue is unknown, 17 but Legionella phospholipids are dominated by w-branched acyl chains rather than palmitate. 25 The molecular basis of the distinct substrate specificity in divergent PagP homologues remains to be determined.
The procedures established for the purification of E. coli PagP from outer membranes provided sufficient enzyme for in vitro assays, 19 but increased yields were necessary before structural biology could become feasible. Towards this goal, Hwang et al. 26 exploited the property of many outer membrane proteins to be expressed as insoluble aggregates in the bacterial cytoplasm when the N-terminal secretory signal peptide is removed. Denaturation and purification of such outer membrane protein aggregates can be followed by refolding in appropriate detergent solutions. Using NMR spectroscopy and in vitro assays, it was possible to verify the refolding of functional E. coli PagP and then to determine the global fold and dynamics of the enzyme in detergent micelles.
PagP is an 8-stranded antiparallel b-barrel preceded by an N-terminal amphipathic a-helix. The b-barrel is well defined in the NMR structure while the extracellular loops are not. Although relaxation measurements indicated that the a-helix is held rigidly in place, its precise positioning could not be determined due to insufficient restraint information connecting the helix to the barrel. Unlike other b-barrel membrane proteins, proline residues at two sites between b-strands disrupt the continuity of hydrogen bonding in the outer leaflet half of the PagP b-barrel. These non-hydrogen bonded regions are located between strands b-1 and b-2, generating a bbulge, and between strands b-6 and b-7. The b-bulge is largely responsible for the highly dynamic nature of the extracellular loop L1. The three putative catalytic residues that were identified by site-directed mutagenesis mapped to the extracellular loops L1 and L2, indicating that the active site is likely localized at the cell surface in the most dynamic region of the molecule.
Small crystals were initially obtained from membranepurified PagP, but isomorphous crystals of much higher quality were obtained from refolded protein. The PagP crystal structure at 1.9Å resolution recently verified the global fold determined by NMR. 27 Although the L1 loop and helix terminus are disordered and cannot be visualized, the helix position can be clearly seen to lie against the barrel. Additional features in the crystal structure include the locations of amino acid side chains, and the visualization of bound detergent and solvent molecules.
Features not seen in any other b-barrel membrane protein include a tilting of the PagP barrel axis by 30°with respect to the membrane normal and the presence of an interior hydrophobic pocket in the upper half of the bbarrel. The hydrophobic pocket harbors a single detergent molecule and functions as a hydrocarbon ruler that allows the enzyme to distinguish palmitate from other acyl chains present in phospholipids. Internalization of phospholipid palmitoyl groups within the barrel interior appears to occur by lateral diffusion through the nonhydrogen bonded regions between the b-strands in the upper half of the molecule. The putative catalytic residues project their side-chains toward the barrel interior and are positioned above the hydrocarbon ruler.
The requirement of invariant His33, Asp76, and Ser77 for catalysis 26 might suggest that PagP utilizes an acylenzyme mechanism characteristic of known serine esterases. However, the putative active site residues are not organized into a catalytic triad that could enhance the nucleophilic character of Ser77 26, 27 and we find that classical serine esterase inhibitors are ineffective against PagP (unpublished observations). The presence of two non-hydrogen bonded regions that could provide simultaneous access for both substrates to the b-barrel interior raises the distinct possibility that PagP catalysis proceeds through the formation of a ternary complex. Such a mechanism could promote the direct transfer of the palmitoyl group from the phospholipid donor to the lipid A acceptor without the formation of an acyl-enzyme intermediate, but the detailed mechanism of PagP catalysis remains to be elucidated.
The clear alignment of the PagP active site with the outer membrane outer leaflet creates an important topological problem for the enzyme. How does PagP access phospholipids if outer membrane lipid asymmetry is maintained? Lipopolysaccharide is located exclusively in the outer membrane outer leaflet while phospholipids are normally restricted to the inner leaflet. 28 The asymmetric organization of outer membrane lipids depends on divalent cations, which bridge negatively charged groups between neighboring lipopolysaccharide molecules. 29 Chelating agents such as EDTA can strip a fraction of lipopolysaccharide from the bacterial surface. 30 A large body of evidence indicates that EDTA promotes the migration of phospholipids into the outer membrane outer leaflet. 31 Indeed, brief treatment of cells with EDTA induces lipid A palmitoylation through a process that occurs more rapidly than induction of the pagP promoter, and is independent of de novo protein synthesis. 32 If EDTA promotes phospholipid translocation to the outer membrane outer leaflet, how are phospholipids replenished in the inner leaflet? The trafficking of phospholipids from the inner membrane to the outer membrane is controlled by the ATP-binding cassette transporter MsbA. 33 As expected, lipid A palmitoylation induced by EDTA in vivo requires functional MsbA. 32 This finding suggests that PagP activity in vivo should require ATP for lipid trafficking even though the PagP transesterification reaction conserves the pre-existing bond energy in the phospholipid donor and, thus, requires no exogenous energy source. We propose that PagP remains dormant in outer membranes until lipid asymmetry is broken under conditions of divalent cation limitation, which is consistent with a role for the Mg 2+sensing PhoP/PhoQ two-component signal transduction pathway in controlling pagP gene expression (Fig. 2) . The delay in responding to assaults on the integrity of the outer membrane through signal transduction may necessitate an additional mechanism that responds instantaneously to changes in outer membrane lipid organization. In this way, PagP becomes exquisitely sensitive to the divalent cations that represent an Achilles' heel of outer membrane structure.
Lipid A palmitoylation is thought to provide resistance to cationic antimicrobial peptides by reducing lipid fluidity and enhancing the tight lateral interactions between neighboring lipopolysaccharide molecules in the outer membrane. 15 The cationic antimicrobial peptides that PagP helps to resist are known to disrupt outer membrane lipid organization. 34 Unlike EDTA, we find that cationic antimicrobial peptides do not activate PagP in vivo and, surprisingly, antagonize the activation by EDTA (unpublished observations). One possible explanation for this finding pertains to the ability of antimicrobial peptides to disrupt vital processes in the inner 110 Bishop, Lo, Khan, El Zoeiby, Jia membrane that are necessary for PagP activity such as lipid trafficking. Another explanation pertains to the avid affinity for lipid A of some cationic peptides, which may sequester lipid A from the PagP active site. Although direct activation of PagP was not observed, recent evidence indicates that cationic antimicrobial peptides can activate PhoP/PhoQ and may, therefore, induce pagP gene expression. 35 A final point of interest lies in the striking structural similarity between PagP and a group of generally soluble lipid-binding proteins known as lipocalins. 27 Like PagP, the lipocalins are 8-stranded antiparallel b-barrels with a deep lipid-binding pocket at one end of the barrel and a flanking a-helix at the other end. Lipocalins are widely distributed among eukaryotes, but are restricted to those bacteria that possess b-barrel membrane proteins. 36 The vast majority of bacterial lipocalins are anchored in outer membranes as lipoproteins. 37 Outer membrane b-barrel domains should be suitably adapted to occupy both soluble and membrane-bound conformations because both environments are encountered during the outer membrane assembly process. Therefore, we cannot currently exclude the hypothesis that PagP and lipocalins share a common ancestor.
Among the known regulated covalent modifications of lipid A, palmitoylation exhibits profound effects on both bacterial and mammalian cells. By revealing the biochemical details of a single lipid A modification, we hope to understand its role in bacterial pathogenesis and to intervene with novel treatments for infection. However, we must remind ourselves that multiple molecular subtypes of lipid A are acting in concert in the bacterial cell. The need to unravel the interactions between individual lipid A modifications will provide fertile ground for future research.
